🚀 RECENT AI SUCCESS

Our AI successfully predicted the gap for $PUB.PA and executed a BUY strategy, securing a +9.52% net profit.

UPGRADE TO SEE LIVE SIGNALS

$RARE

Ultragenyx Pharmaceutical Inc.

United StatesUNITED STATES
FREE PREVIEW
📅 Next Earnings: Aug 04, 2026 🌙 Close🌐 Website🏛️ NASDAQ📁 Health Technology🏭 Pharmaceuticals Major
AVG HISTORICAL GAP0.25%
MAX GAP RECORD-10.97%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

VOLATILITY & BIAS PROFILE

AVG VOLATILITY3.9%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA. Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL

AI INSIGHTS & REPORTS FOR RARE

AI REPORT Jul 10

Daily Champion Stocks: Top 3 Opportunities You Can’t Afford to Miss

AnalysisDiscover how Daily Champions are driving the market with these top-performing stocks. Whether you’re a seasoned investor or…
VIEW REPORT_